Novavax Stock Up on Swiss Approval of Nuvaxovid
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Novavax’s Covid-19 vaccine Nuvaxovid just got approved for in Switzerland. NVAX stock is up on news. It couldn’t have come at a better time.
The post Novavax Stock Up on Swiss Approval of Nuvaxovid appeared first on InvestorPlace.
More From InvestorPlace